ArticleScientific reports2025
Prediction model for extrathyroidal extension in thyroid papillary carcinoma based on ultrasound radiomics.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Preoperative prediction of extrathyroidal extension in papillary thyroid carcinoma: a nomogram integrating dual-plane ultrasound-based radiomics and clinical features.Gland surgery · 2026Article
- Super-resolution ultrasound radiomics for pre-FNA prediction of nondiagnostic (Bethesda I) thyroid nodules.Frontiers in endocrinology · 2026Article
- The relationship between the extent of extrathyroidal extension and lymph node metastasis based on propensity score matching analysis.Gland surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study aimed to construct preoperative prediction models for extrathyroidal extension (ETE) in papillary thyroid carcinoma (PTC) based on ultrasonic radiomics and explore their clinical application value. This retrospective study included PTC patients treated across three centers from 2015 to 2023. Data for 609 cases from two centers were utilized for model construction and divided 4:1 into a training set (n = 487; 144 with ETE and 343 without ETE) and test set (n = 122; 58 with ETE and 64 without ETE). The external validation set comprised 109 PTC patients from the third center (n = 109; 55 with ETE and 54 without ETE). Image features were extracted using Pyradiomics. Feature selection and dimensionality reduction were performed using the least absolute shrinkage and selection operator and principal component analysis to construct radiomics models. Model performance was evaluated by receiver operating characteristic (ROC) curve analysis, and clinical benefit was assessed by decision curve analysis. A total of 806 radiomics features were extracted from the training set data. After feature selection and dimensionality reduction, six significant features were included in the models, including one gray-level size zone matrix feature, one shape feature, one first-order feature, one gray-level run-length matrix feature, and two gray-level co-occurrence matrix features. The extreme gradient boosting (XGB) model showed the best performance in both the test and external validation sets, with area under the ROC curve values of 0.841 and 0.814, respectively. In conclusion, the XGB preoperative ETE prediction model for PTC based on ultrasonic radiomics offers good clinical application value for decision-making regarding therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.